Bad Influence? U.K. Questions Pharma’s Sway On Health Care System
This article was originally published in The Pink Sheet Daily
Executive Summary
House of Commons hearings are scheduled throughout the rest of the year to examine pharmaceutical companies’ influence on all facets of the U.K. health care system. Health committee will focus attention on government agencies, marketing practices and physician education.